Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Inflammatory Disorder Equipment Supplied In Europe
4 equipment items found
Manufactured by:Gesynta Pharma AB based inStockholm, SWEDEN
Microsomal prostaglandin E synthase (mPGES-1) is an enzyme generally present at low levels in the human body. It stimulates production of prostaglandin E2 (PGE2), a potent biological messenger that has a pronounced impact on inflammation. During inflammation the levels of mPGES-1 are upregulated, causing excessive levels of PGE2, which drive the inflammatory symptoms. ...
Manufactured by:Chirana Progress, s.r.o based inPieštany, SLOVAKIA
The whole body galavnic bath Electra CG is designed to provide application of galvanic current in water on the upper and lower extremities. While flowing from one limb to another, the galvanic current causes polarization of the tissues. This polarization can be considerred as an intracellular and extracellular temporary disorder of the dynamic metabolic derangement. The body protects against this ...
Manufactured by:Chirana Progress, s.r.o based inPieštany, SLOVAKIA
The limb galavnic bath Electra is designed to provide application of galvanic current in water on the upper and lower extremities. While flowing from one limb to another, the galvanic current causes polarization of the tissues. This polarization can be considerred as an intracellular and extracellular temporary disorder of the dynamic metabolic derangement. The body protects against this ...
Manufactured by:Firalis Group based inHuningue, FRANCE
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...